{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T17:49:24Z","timestamp":1795110564673,"version":"4.10.3"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:p>This study aims to review institutional algorithms for vaso-occlusive crisis (VOC) and acute chest syndrome (ACS) in pediatric sickle cell disease (SCD), comparing them to each other and to national recommendations. Algorithms collected from children\u2019s hospitals across the country were compared with recommendations made by the National Heart, Lung, and Blood Institute 2014 and the American Society of Hematology 2020 regarding management of VOC\/ACS in SCD. Review of 37 VOC and 17 ACS algorithms from 40 children\u2019s hospitals showed that most followed national guidelines for diagnostic evaluation of VOC\/ACS. Parenteral opioids and NSAIDs were recommended by all VOC algorithms, with variations in dosing and administration. Intranasal fentanyl was recommended by 31 algorithms. Incentive spirometry was included in 16 of 17 ACS algorithms, but only in 11 of 37 VOC algorithms. Antibiotics were recommended by all ACS algorithms, but 4 used regimens were different from national recommendations. Most ACS algorithms had recommendations regarding transfusion, but with considerable variability. Intravenous fluid management strategies were highly variable, and hypotonic fluids were recommended in 6 VOC and 4 ACS algorithms. Overall, internal algorithms for pediatric SCD showed variability compared with each other and with national guidelines, likely due to the lack of robust evidence supporting specific recommendations.<\/jats:p>","DOI":"10.1097\/mph.0000000000003052","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T19:00:10Z","timestamp":1747249210000},"page":"e155-e160","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Variability in the Recommendations for Management of Vaso-occlusive Crisis and Acute Chest Syndrome in Sickle Cell Disease: Review of Institutional Algorithms of Pediatric Hospitals Across the United States"],"prefix":"10.1097","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7970-7516","authenticated-orcid":false,"given":"Amr","family":"Elgehiny","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Pediatric Hematology Oncology, The University of Texas, MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam Z.","family":"Quraishi","sequence":"additional","affiliation":[{"name":"CUNY School of Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravind","family":"Yadav","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, McGovern Medical School at the University of Texas Health Science Center at Houston and Children\u2019s Memorial Hermann Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi V.","family":"Srivaths","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, McGovern Medical School at the University of Texas Health Science Center at Houston and Children\u2019s Memorial Hermann Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olayinka","family":"Okeleji","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Pediatric Hematology Oncology, The University of Texas, MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah L.","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, McGovern Medical School at the University of Texas Health Science Center at Houston and Children\u2019s Memorial Hermann Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neethu M.","family":"Menon","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, McGovern Medical School at the University of Texas Health Science Center at Houston and Children\u2019s Memorial Hermann Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"R3-20250623","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/jamapediatrics.2017.2526","article-title":"Association of guideline-adherent antibiotic treatment with readmission of children with sickle cell disease hospitalized with acute chest syndrome","volume":"171","author":"Bundy","year":"2017","journal-title":"JAMA Pediatr"},{"key":"R4-20250623","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/pbc.24864","article-title":"Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease","volume":"61","author":"Ender","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"R5-20250623","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/pbc.21847","article-title":"Clinical practice guideline improves the treatment of sickle cell disease vasoocclusive pain","volume":"52","author":"Morrissey","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"R6-20250623","doi-asserted-by":"crossref","first-page":"e30879","DOI":"10.1002\/pbc.30879","article-title":"Oxygen saturation thresholds in managing sickle cell disease at US children's hospitals.","volume":"71","author":"Yadav","year":"2024","journal-title":"Pediatr Blood Cancer"},{"key":"R7-20250623","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jen.2021.06.002","article-title":"It\u2019s time to provide evidence-based care to individuals with sickle cell disease: a call to action","volume":"47","author":"Tanabe","year":"2021","journal-title":"J Emerg Nurs"},{"key":"R8-20250623","doi-asserted-by":"crossref","first-page":"e26742","DOI":"10.1002\/pbc.26742","article-title":"Variations in pediatric emergency medicine physician practices for intravenous fluid management in children with sickle cell disease and vaso-occlusive pain: A single institution experience","volume":"65","author":"Carden","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"R9-20250623","doi-asserted-by":"crossref","first-page":"524513","DOI":"10.5402\/2012\/524513","article-title":"Transfusion practices in the management of sickle cell disease: a survey of Florida hematologists\/oncologists.","volume":"2012","author":"Dunbar","year":"2012","journal-title":"ISRN Hematol"},{"key":"R10-20250623","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00006565-199704000-00005","article-title":"Pediatric emergency department analgesic practice","volume":"13","author":"Friedland","year":"1997","journal-title":"Pediatr Emerg Care"},{"key":"R11-20250623","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.annemergmed.2013.02.004","article-title":"Emergency provider analgesic practices and attitudes toward patients with sickle cell disease","volume":"62","author":"Glassberg","year":"2013","journal-title":"Ann Emerg Med"},{"key":"R12-20250623","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1537-2995.2007.01484.x","article-title":"Blood transfusions in children: a multi-institutional analysis of practices and complications","volume":"48","author":"Slonim","year":"2008","journal-title":"Transfusion"},{"key":"R13-20250623","doi-asserted-by":"crossref","first-page":"E412","DOI":"10.1002\/ajh.26696","article-title":"Adherence to NHLBI guidelines for the emergent management of vaso-occlusive episodes in children with sickle cell disease: a multicenter perspective","volume":"97","author":"Rees","year":"2022","journal-title":"Am J Hematol"},{"key":"R14-20250623","doi-asserted-by":"crossref","first-page":"e050880","DOI":"10.1136\/bmjopen-2021-050880","article-title":"Identifying barriers to evidence-based care for sickle cell disease: results from the Sickle Cell Disease Implementation Consortium cross-sectional survey of healthcare providers in the USA","volume":"11","author":"Smeltzer","year":"2021","journal-title":"BMJ Open"},{"key":"R15-20250623","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/bloodadvances.2020001851","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain","volume":"4","author":"Brandow","year":"2020","journal-title":"Blood Adv"},{"key":"R16-20250623","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"Jama"},{"key":"R17-20250623","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population Estimates of Sickle Cell Disease in the U.S.","volume":"38","author":"Hassell","year":"2010","journal-title":"Am J Prev Med"},{"key":"R18-20250623","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/bloodadvances.2019001143","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support","volume":"4","author":"Chou","year":"2020","journal-title":"Blood Adv"},{"key":"R19-20250623","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ajem.2017.07.037","article-title":"Opioid doses and acute care utilization outcomes for adults with sickle cell disease: ED versus acute care unit","volume":"36","author":"Molokie","year":"2018","journal-title":"Am J Emerg Med"},{"key":"R20-20250623","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1007\/s11606-023-08392-0","article-title":"The bias of medicine in sickle cell disease","volume":"38","author":"Anderson","year":"2023","journal-title":"J Gen Intern Med"},{"key":"R21-20250623","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.annemergmed.2006.06.016","article-title":"A randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency department","volume":"49","author":"Borland","year":"2007","journal-title":"Ann Emerg Med"},{"key":"R22-20250623","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/ajh.26871","article-title":"Intranasal fentanyl works-Why are we not using it more to treat acute pain in sickle cell disease?","volume":"98","author":"Oni","year":"2023","journal-title":"Am J Hematol"},{"key":"R23-20250623","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/ajh.26837","article-title":"Intranasal fentanyl and discharge from the emergency department among children with sickle cell disease and vaso-occlusive pain: a multicenter pediatric emergency medicine perspective","volume":"98","author":"Rees","year":"2023","journal-title":"Am J Hematol"},{"key":"R24-20250623","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM199509143331104","article-title":"Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases","volume":"333","author":"Bellet","year":"1995","journal-title":"N Engl J Med"},{"key":"R25-20250623","first-page":"Cd005406","article-title":"Fluid replacement therapy for acute episodes of pain in people with sickle cell disease","volume":"7","author":"Okomo","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R26-20250623","doi-asserted-by":"crossref","first-page":"e30781","DOI":"10.1002\/pbc.30781","article-title":"Intravenous fluid therapy and hospital outcomes for vaso-occlusive episodes in children, adolescents, and young adults with sickle cell disease","volume":"71","author":"Haimed","year":"2024","journal-title":"Pediatric Blood Cancer"},{"key":"R27-20250623","doi-asserted-by":"crossref","first-page":"159","DOI":"10.14740\/jh1058","article-title":"Intravenous Fluid Administration and the Risk of Adverse Outcomes in Sickle Cell Disease Patients Hospitalized for Vaso-Occlusive Crisis.","volume":"11","author":"Ojo","year":"2022","journal-title":"J Hematol"},{"key":"R28-20250623","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ajh.25471","article-title":"Normal saline bolus use in pediatric emergency departments is associated with poorer pain control in children with sickle cell anemia and vaso-occlusive pain","volume":"94","author":"Carden","year":"2019","journal-title":"Am J Hematol"},{"key":"R29-20250623","first-page":"1","article-title":"Fluid replacement strategies in sickle cell disease","volume":"21","author":"Jones","year":"2017","journal-title":"Proc UCLA Healthcare"},{"key":"R30-20250623","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.annemergmed.2020.08.011","article-title":"Association of antibiotic choice with hospital length of stay and risk factors for readmission in patients with sickle cell disease and acute chest syndrome: an observational cohort study","volume":"76","author":"Badaki-Makun","year":"2020","journal-title":"Ann Emerg Med"},{"key":"R31-20250623","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jama.2010.378","article-title":"Acute care utilization and rehospitalizations for sickle cell disease","volume":"303","author":"Brousseau","year":"2010","journal-title":"Jama"},{"key":"R32-20250623","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease\u2013life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"key":"R33-20250623","first-page":"1855","article-title":"Causes and outcomes of the acute chest syndrome in sickle cell disease","volume":"342","author":"Vichinsky","year":"2000","journal-title":"Natnl Acute Chest Syndr Study Group N Engl J Med"},{"key":"R34-20250623","doi-asserted-by":"crossref","first-page":"150755","DOI":"10.1016\/j.tmrv.2023.150755","article-title":"Acute Chest Syndrome in Sickle Cell Disease.","volume":"37","author":"Bhasin","year":"2023","journal-title":"Transfus Med Rev"},{"key":"R35-20250623","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/pbc.22211","article-title":"Erythrocytapheresis in children with sickle cell disease and acute chest syndrome","volume":"53","author":"Velasquez","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"R37-20250623","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/ped.2017.0814","article-title":"Acute chest syndrome in children with sickle cell disease","volume":"30","author":"Jain","year":"2017","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"key":"R38-20250623","first-page":"5297","article-title":"How I treat acute chest syndrome in children with sickle cell disease","volume":"117","author":"Miller","year":"2011","journal-title":"Blood J Am Society Hematol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003052","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T15:00:32Z","timestamp":1750690832000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003052","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"2024-08-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}